Stockscreener 앱 받기
9.66
1.43%
-0.14
시장 영업 전:
9.67
0.010
+0.10%
Biocryst Pharmaceuticals Inc 주식(BCRX)의 최신 뉴스
Insider Sell: Theresa Heggie Sells 49,933 Shares of BioCryst Pha - GuruFocus
Major Insider Move at BioCryst Shakes Up Investor Buzz - TipRanks
Buybacks Report: Is BioCryst Pharmaceuticals Inc benefiting from interest rate changes2026 Snapshot & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Hereditary Angioedema Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Domain | DelveInsight - Barchart.com
Biocryst Pharmaceuticals Insider Sold Shares Worth $504,823, According to a Recent SEC Filing - marketscreener.com
Option exercise and sale by BioCryst (BCRX) director Theresa Heggie - Stock Titan
BioCryst Pharmaceuticals (NASDAQ:BCRX) Shares Gap UpWhat's Next? - MarketBeat
BioCryst stock jumps after hours on big pharma suitor buzz — retail sentiment hits 2026 peak - MSN
Why Did BCRX Stock Surge Over 10% In After-Hours Trading Today? - Stocktwits
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Trading the Move, Not the Narrative: (BCRX) Edition - Stock Traders Daily
BioCryst (BCRX) rallies 7.10% on acquisition buzz - MSN
Portfolio Update: Is BioCryst Pharmaceuticals Inc subject to activist investor interest2026 Market Trends & Fast Moving Stock Trade Plans - baoquankhu1.vn
Aug Sectors: Is BioCryst Pharmaceuticals Inc benefiting from interest rate changes2026 Spike Watch & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Form 144 BIOCRYST PHARMACEUTICALS INC For: 20 March - Investing.com
[144] BIOCRYST PHARMACEUTICALS INC SEC Filing - Stock Titan
BioCryst (BCRX) Rallies 7.10% on Acquisition Buzz - Insider Monkey
BCRX Should I Buy - Intellectia AI
BioCryst Pharmaceuticals, Inc. (BCRX) A Good Stock To Buy Now? - Insider Monkey
BioCryst Takeover Rumors Test Investor Focus On Fundamentals And Optionality - Yahoo Finance
BCRX Technical Analysis | Trend, Signals & Chart Patterns | BIOCRYST PHARMACEUTICALS INC (NASDAQ:BCRX) - ChartMill
BioCryst (BCRX) chief legal officer Barnes sells $1.37m in shares By Investing.com - Investing.com South Africa
BioCryst Pharmaceuticals: Why This $2B Drugmaker Is Suddenly On Big Pharma’s Radar! - Smartkarma
BioCryst (BCRX) chief legal officer Barnes sells $1.37m in shares - Investing.com India
BCRX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
BioCryst Pharmaceuticals (NASDAQ:BCRX) Insider Sells $1,372,500.00 in Stock - MarketBeat
BioCryst (BCRX) CLO sells 150K shares after option exercise - Stock Titan
Is It Time To Reconsider BioCryst Pharmaceuticals (BCRX) After Recent Share Price Strength - Sahm
A Look At BioCryst Pharmaceuticals (BCRX) Valuation After Its Profitability And Revenue Turnaround - Sahm
BioCryst: The Buyout Rumor Is Noise, The Franchise Is Real (NASDAQ:BCRX) - Seeking Alpha
BioCryst (BCRX) Soars 13% on Acquisition Buzz - Insider Monkey
BioCryst Pharmaceuticals Stock Jumps 13.8% - National Today
10 Stocks Worth Watching Right Now: Tencent, Circle, BioCryst and More - Insider Monkey
BioCryst Pharmaceuticals jumps as investors revisit profitable 2025 results, upbeat HAE pipeline data, and potential short-covering dynamics - Quiver Quantitative
Form 144 resale notice lists 150,000 shares (NASDAQ: BCRX) - Stock Titan
BioCryst Pharmaceuticals (NASDAQ:BCRX) Stock Price Up 13.8%Here's What Happened - MarketBeat
BioCryst Pharmaceuticals Sees Profitable Quarter Amid Strategic Moves - StocksToTrade
BioCryst gains amid takeover speculation - MSN
Top Biotech Stocks To Keep An Eye OnMarch 16th - MarketBeat
BioCryst Stock Surges After Strong Q4 Earnings and Astria Acquisition - timothysykes.com
BioCryst Pharmaceuticals (BCRX) Surges 15% Amid Takeover Specula - GuruFocus
BioCryst Stock Surges on Profit Milestone and Upgrades - TipRanks
Alkeon Capital Management LLC Trims Position in BioCryst Pharmaceuticals, Inc. $BCRX - MarketBeat
Avoro Capital Advisors Trims Stake in BioCryst Pharmaceuticals - National Today
Avoro Capital Advisors LLC Trims Stock Position in BioCryst Pharmaceuticals, Inc. $BCRX - MarketBeat
Whale Trades: Will BioCryst Pharmaceuticals Inc benefit from green energy policiesMarket Activity Recap & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
(BCRX) Volatility Zones as Tactical Triggers - Stock Traders Daily
BioCryst Pharma (BCRX) Subject to Prise Target Raise by Wedbush - Finviz
10 Most Shorted Biotech Stocks to Buy According to Hedge Funds - Insider Monkey
BioCryst outlines $625M–$645M 2026 ORLADEYO revenue target as HAE pipeline advances - MSN
BioCryst Pharmaceuticals, Inc. $BCRX Shares Sold by GW&K Investment Management LLC - MarketBeat
BioCryst Pharmaceuticals, Inc. $BCRX Shares Sold by Knott David M Jr - MarketBeat
BCRXBioCryst Reports Full Year 2025 Financial Results and Provides Business Update - mx.advfn.com
Evercore ISI sees long-term growth potential for BioCryst Pharmaceuticals, Inc. (BCRX) following Astria acquisition - MSN
BioCryst Pharmaceuticals Conference: Profitability Pivot, ORLADEYO Growth, Navenibart Phase 3 Timeline - MarketBeat
1.75%
1.88%
자본화:
|
볼륨(24시간):